Ambea ABCHIX:AMBEAS 82 Buyback Yield % is 2.16 as of Jul. 04, 2026. GuruFocus rates CHIX:AMBEAS with a GF Score™ of 82/100 and a GF Value™ of kr110.27 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 272 Healthcare Providers & Services companies, Ambea AB ranks better than 80.88% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Ambea AB's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:AMBEAS vs HCA, THC, DVA: Buyback Yield % Comparison
For the Medical Care Facilities subindustry, Ambea AB's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ambea AB Buyback Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ambea AB's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Ambea AB's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ambea AB (CHIX:AMBEAS) has a Buyback Yield % of 2.16 as of Jul. 04, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Ambea AB and its competitors. According to the industry distribution chart, Ambea AB ranks #52 out of 272 companies in the Healthcare Providers & Services industry, placing it in the top 19.1%.
Is Ambea AB's Buyback Yield % too high?
Ambea AB's current Buyback Yield % is 2.16. Based on the distribution chart, Ambea AB ranks #52 out of 272 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Ambea AB has a GF Score™ of 82/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ambea AB's Buyback Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ambea AB ranks #52 out of 272 companies for Buyback Yield %. This places Ambea AB in the top 19% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Ambea AB and its competitors. Ambea AB's current Buyback Yield % is 2.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambea AB stock overvalued right now?
Based on GuruFocus' analysis, Ambea AB (CHIX:AMBEAS) is currently considered Significantly Overvalued. The stock's GF Value™ is kr110.27, compared to a current price of kr153.95 — trading 39.6% above its estimated fair value. The current Buyback Yield % is 2.16. Ambea AB's overall GF Score™ is 82/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Ambea AB (CHIX:AMBEAS), the current Buyback Yield % is 2.16 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ambea AB (CHIX:AMBEAS) Overvalued in 2026?
Based on GuruFocus' analysis, Ambea AB stock appears to be overvalued.
The current stock price of kr153.95 is trading 39.6% above its estimated GF Value™ of kr110.27.
GuruFocus considers Ambea AB to be Significantly Overvalued.
Key valuation signals for CHIX:AMBEAS:
Buyback Yield %: 2.16
GF Value™: kr110.27 vs. price of kr153.95 (39.6% above fair value)
No single metric tells the full story. See the CHIX:AMBEAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ambea AB is a Swedish care-provider group focused on elderly care, disability care, psychosocial support, housing, staffing, and training across the Nordic region. The company's segment includes: i) Nytida: Comprises social care services for children, youth and adults, in Sweden, ii) Vardaga: Comprises nursing homes and home care in Sweden, iii) Stendi: Comprises social care for children, youth and adult in Norway, iv) Validia: Comprises social care for children, v) Altiden: Comprises social care for children, youth and adults as well as elderly care in Denmark, and vi) Klara: Comprises competence and staffing solutions for elderly and social care, and student health services in Sweden. The majority of the company's revenue is derived from the Vardaga segment.
82GF Score
Get the complete analysis for CHIX:AMBEAS
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:AMBEAS has been successfully added to your 
